Characteristics of pericardial interstitial cells and their implications in pericardial fibrocalcification

Journal of Molecular and Cellular Cardiology

Volumn 53, Issue 6, 2012, Pages 780-789

  Liu, Xiaohong ^a   Tan, Mengwei ^a   Gong, Dejun ^a   Han, Lin ^a   Lu, Fanglin ^a   Huang, Shengdong ^a   Xu, Zhiyun ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Biology; Fibrocalcification; Pericardial interstitial cells; Phenotypic plasticity; Self renewal; Transdifferentiation

Indexed keywords

ALKALINE PHOSPHATASE; ALPHA SMOOTH MUSCLE ACTIN; BONE MORPHOGENETIC PROTEIN 2; KRUPPEL LIKE FACTOR 2; MESSENGER RNA; OCTAMER TRANSCRIPTION FACTOR 4; PLATELET DERIVED GROWTH FACTOR AA; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL AGING; CELL RENEWAL; CELL TRANSDIFFERENTIATION; COLONY FORMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; HEART MUSCLE CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MYOFIBROBLAST; OSTEOBLAST; PATHOGENESIS; PERICARDIAL DISEASE; PERICARDIAL FIBROCALCIFICATION; PERICARDIAL INTERSTITIAL CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

CALCINOSIS; CARDIOMYOPATHIES; CELL PROLIFERATION; CELL TRANSDIFFERENTIATION; CELLS, CULTURED; CONNECTIVE TISSUE CELLS; FIBROBLASTS; FIBROSIS; HUMANS; IMMUNOPHENOTYPING; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MYOBLASTS; OCTAMER TRANSCRIPTION FACTOR-3; OSTEOBLASTS; PERICARDIUM;

EID: 84869093394     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2012.09.008     Document Type: Article

References (41)

1. Oh J.K., Tajik A.J., Appleton C.P., Hatle L.K., Nishimura R.A., Seward J.B. Preload reduction to unmask the characteristic Doppler features of constrictive pericarditis. A new observation. Circulation 1997, 95:796-799.
2. Little W.C., Freeman G.L. Pericardial disease. Circulation 2006, 113:1622-1632.
3. Bertog S.C., Thambidorai S.K., Parakh K., Schoenhagen P., Ozduran V., Houghtaling P.L., et al. Constrictive pericarditis: etiology and cause-specific survival after pericardiectomy. J Am Coll Cardiol 2004, 43:1445-1452.
4. Ling L.H., Oh J.K., Breen J.F., Schaff H.V., Danielson G.K., Mahoney D.W., et al. Calcific constrictive pericarditis: is it still with us?. Ann Intern Med 2000, 132:444-450.
5. Talreja D.R., Edwards W.D., Danielson G.K., Schaff H.V., Tajik A.J., Tazelaar H.D., et al. Constrictive pericarditis in 26 patients with histologically normal pericardial thickness. Circulation 2003, 108:1852-1857.
6. Dahm M., Prüfer D., Mayer E., Groh E., Choi Y.H., Oelert H. Early failure of an autologous pericardium aortic heart valve (ATCV) prosthesis. J Heart Valve Dis 1998, 7:30-33.
7. Frater R.W., Berghuis J., Brown A.L., Ellis F.H. Autogenous pericardium for posterior mitral leaflet replacement. Surgery 1963, 54:260-269.
8. Schlichter A.J., Kreutzer C., Mayorquim R.C., Simon J.L., Román M.I., Vazquez H., et al. Five- to fifteen-year follow-up of fresh autologous pericardial valved conduits. J Thorac Cardiovasc Surg 2000, 119:869-879.
9. Hibino N., Shin'oka T., Kurosawa H. Long-term histologic findings in pulmonary arteries reconstructed with autologous pericardium. N Engl J Med 2003, 348:865-867.
10. Cheung D.T., Choo S.J., Grobe A.C., Marchion D.C., Luo H.H., Pang D.C., et al. Behavior of vital and killed autologous pericardium in the descending aorta of sheep. J Thorac Cardiovasc Surg 1999, 118:998-1005.
11. Liu X., Bai C., Gong D., Yuan Y., Han L., Lu F., et al. Pleiotropic effects of transforming growth factor-β1 on pericardial interstitial cells. Implications for fibrosis and calcification in idiopathic constrictive pericarditis. J Am Coll Cardiol 2011, 57:1634-1635.
12. Osman L., Yacoub M.H., Latif N., Amrani M., Chester A.H. Role of human valve interstitial cells in valve calcification and their response to atorvastatin. Circulation 2006, 114:I547-I552.
13. Farrington-Rock C., Crofts N.J., Doherty M.J., Ashton B.A., Griffin-Jones C., Canfield A.E. Chondrogenic and adipogenic potential of microvascular pericytes. Circulation 2004, 110:2226-2232.
14. Tan J.T., McLennan S.V., Song W.W., Lo L.W., Bonner J.G., Williams P.F., et al. Connective tissue growth factor inhibits adipocyte differentiation. Am J Physiol Cell Physiol 2008, 295:C740-C751.
15. Aggarwal S., Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005, 105:1815-1822.
16. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
17. Schlatmann T.J., Becker A.E. Histologic changes in the normal aging aorta: implications for dissecting aortic aneurysm. Am J Cardiol 1977, 39:13-20.
18. Mohler E.R., Gannon F., Reynolds C., Zimmerman R., Keane M.G., Kaplan F.S. Bone formation and inflammation in cardiac valves. Circulation 2001, 103:1522-1528.
19. Blais C., Burwash I.G., Mundigler G., Dumesnil J.G., Loho N., Rader F., et al. Projected valve area at normal flow rate improves the assessment of stenosis severity in patients with low-flow, low-gradient aortic stenosis: the multicenter TOPAS (Truly or Pseudo-Severe Aortic Stenosis) study. Circulation 2006, 113:711-721.
20. Reifart N., Nowak B., Baykut D., Satter P., Bussmann W.D., Kaltenbach M. Experimental balloon valvuloplasty of fibrotic and calcific mitral valves. Circulation 1990, 81:1005-1011.
21. He T.C., Zhou S., da Costa L.T., Yu J., Kinzler K.W., Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 1998, 95:2509-2514.
22. Pfister O., Mouquet F., Jain M., Summer R., Helmes M., Fine A., et al. CD31- but Not CD31+ cardiac side population cells exhibit functional cardiomyogenic differentiation. Circ Res 2005, 97:52-61.
23. Oh K.Y., Shimizu M., Edwards W.D., Tazelaar H.D., Danielson G.K. Surgical pathology of the parietal pericardium: a study of 344 cases (1993-1999). Cardiovasc Pathol 2001, 10:157-168.
24. Emri G., Wenczl E., Van Erp P., Jans J., Roza L., Horkay I., et al. Low doses of UVB or UVA induce chromosomal aberrations in cultured human skin cells. J Invest Dermatol 2000, 115:435-440.
25. van Tuyn J., Atsma D.E., Winter E.M., van der Velde-van Dijke I., Pijnappels D.A., Bax N.A., et al. Epicardial cells of human adults can undergo an epithelial-to-mesenchymal transition and obtain characteristics of smooth muscle cells in vitro. Stem Cells 2007, 25:271-278.
26. Loh Y.H., Wu Q., Chew J.L., Vega V.B., Zhang W., Chen X., et al. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet 2006, 38:431-440.
27. Kim J.B., Greber B., Araúzo-Bravo M.J., Meyer J., Park K.I., Zaehres H., et al. Direct reprogramming of human neural stem cells by OCT4. Nature 2009, 461:649-3.
28. Jiang J., Chan Y.S., Loh Y.H., Cai J., Tong G.Q., Lim C.A., et al. A core Klf circuitry regulates self-renewal of embryonic stem cells. Nat Cell Biol 2008, 10:353-360.
29. Lyssiotis C.A., Foreman R.K., Staerk J., Garcia M., Mathur D., Markoulaki S., et al. Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4. Proc Natl Acad Sci U S A 2009, 106:8912-8917.
30. Shi Y., O'Brien J.E., Mannion J.D., Morrison R.C., Chung W., Fard A., et al. Remodeling of autologous saphenous vein grafts. The role of perivascular myofibroblasts. Circulation 1997, 95:2684-2693.
31. Patel S., Shi Y., Niculescu R., Chung E.H., Martin J.L., Zalewski A. Characteristics of coronary smooth muscle cells and adventitial fibroblasts. Circulation 2000, 101:524-532.
32. Xu Y., Pritzker K.P., Cruz T.F. Characterization of chondrocyte alkaline phosphatase as a potential mediator in the dissolution of calcium pyrophosphate dihydrate crystals. J Rheumatol 1994, 21:912-919.
33. Whyte M.P. Physiological role of alkaline phosphatase explored in hypophosphatasia. Ann N Y Acad Sci 2010, 1192:190-200.
34. Clark-Greuel J.N., Connolly J.M., Sorichillo E., Narula N.R., Rapoport H.S., Mohler E.R., et al. Transforming growth factor-beta1 mechanisms in aortic valve calcification: increased alkaline phosphatase and related events. Ann Thorac Surg 2007, 83:946-953.
35. Tanimura A., McGregor D.H., Anderson H.C. Matrix vesicles in atherosclerotic calcification. Proc Soc Exp Biol Med 1983, 172:173-177.
36. Prince M., Banerjee C., Javed A., Green J., Lian J.B., Stein G.S., et al. Expression and regulation of Runx2/Cbfa1 and osteoblast phenotypic markers during the growth and differentiation of human osteoblasts. J Cell Biochem 2001, 80:424-440.
37. Banerjee C., Javed A., Choi J.Y., Green J., Rosen V., van Wijnen A.J., et al. Differential regulation of the two principal Runx2/Cbfa1 n-terminal isoforms in response to bone morphogenetic protein-2 during development of the osteoblast phenotype. Endocrinology 2001, 142:4026-4039.
38. Hu B., Wu Z., Liu T., Ullenbruch M.R., Jin H., Phan S.H. Gut-enriched Krüppel-like factor interaction with Smad3 inhibits myofibroblast differentiation. Am J Respir Cell Mol Biol 2007, 36:78-84.
39. Zhao T., Zhang Z.N., Rong Z., Xu Y. Immunogenicity of induced pluripotent stem cells. Nature 2011, 474:212-215.
40. Mauritz C., Martens A., Rojas S.V., Schnick T., Rathert C., Schecker N., et al. Induced pluripotent stem cell (iPSC)-derived Flk-1 progenitor cells engraft, differentiate, and improve heart function in a mouse model of acute myocardial infarction. Eur Heart J 2011, 32:2634-2641.
41. Hester M.E., Song S., Miranda C.J., Eagle A., Schwartz P.H., Kaspar B.K. Two factor reprogramming of human neural stem cells into pluripotency. PLoS One 2009, 4:e7044.